3 documents found, page 1 of 1
Translating Results From the Cardiovascular Outcomes Trials with Glucagon-Like ...
Janez, A; Muzurovic, E; Stoian, A; Haluzik, M; Guja, C; Czupryniak, L; Duvnjak, L; Lalic, N; Tankova, T; Bogdanski, P; Papanas, N; Silva Nunes, JGlucagon-like peptide-1 (GLP-1) receptor agonists mimic the action of the endogenous GLP-1 incretin hormone, improving glycaemic control in type 2 diabetes mellitus (T2DM) by increasing insulin secretion and decreasing glucagon secretion in a glucose-dependent manner. However, as cardiovascular (CV) morbidity and mortality is common in patients with T2DM, several trials with the use of GLP-1 receptor agonists (...
Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients...
Kotseva, K; De Backer, G; De Bacquer, D; Rydén, L; Hoes, A; Grobbee, D; Maggioni, A; Marques-Vidal, P; Jennings, C; Abreu, A; Aguiar, C; Badariene, JAims: The aim of this study was to determine whether the Joint European Societies guidelines on secondary cardiovascular prevention are followed in everyday practice. Design: A cross-sectional ESC-EORP survey (EUROASPIRE V) at 131 centres in 81 regions in 27 countries. Methods: Patients (<80 years old) with verified coronary artery events or interventions were interviewed and examined ≥6 months later. Results: ...
Lifestyle and Risk Factor Management in People at High Risk of Cardiovascular D...
Kotseva, K; De Bacquer, D; De Backer, G; Rydén, L; Jennings, C; Gyberg, V; Abreu, A; Aguiar, C; Conde, Almudena C; Davletov, K; Dilic, M; Dolzhenko, MBACKGROUND: European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV in primary care was a cross-sectional survey carried out by the European Society of Cardiology, EURObservational Research Programme in 2014-2015 in 71 centres from 14 European countries. The main objective was to determine whether the 2012 Joint European Societies' guidelines on cardiovascular diseas...